LUMIGAN® 0.01% is the #1 dispensed branded glaucoma medication1

WHEN IT COMES TO THE
PRESSURE OF YOUR GLAUCOMA
DON'T COMPROMISE

See why LUMIGAN® 0.01% may be right for lowering the high eye pressure of your open-angle glaucoma or ocular hypertension

Lumigan Logo

There is no FDA-approved generic version of LUMIGAN® 0.01%.

There is no FDA-approved generic version of LUMIGAN® 0.01%.

Eligible patients may pay as little as

$15 FOR 90 DAYS OF MEDICATION*

That’s as little as $5 per month for a 90-day supply. Ask your doctor to switch to a 90-day prescription and start saving today.

You can also enroll for discounts by

Calling

1-833-DIAL-AYS

(1-833-342-5297)
OR
Texting

SAVINGS TO 72428

You can also enroll for discounts by

Calling

1-833-DIAL-AYS

(1-833-342-5297)
Or Texting

SAVINGS TO 72428

*Offer not valid for patients enrolled in Medicare, Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs (such as medical assistance programs). Other limitations may apply. This offer is valid for up to 12 prescription fills for a 30-day supply and 4 prescription fills for a 90-day supply per medication. Offer applies only to prescriptions filled before the program expires on 05/01/20. This offer cannot be combined with any other programs, offers, or discounts, and may not be redeemed for cash. Allergan reserves the right to rescind, revoke, or amend this offer without notice at any time.

INDICATION

LUMIGAN® (bimatoprost ophthalmic solution) 0.01% is used for the reduction of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or ocular hypertension.

IMPORTANT SAFETY INFORMATION

Do not use LUMIGAN® (bimatoprost ophthalmic solution) 0.01% if you are allergic to any of the ingredients.

LUMIGAN® 0.01% can cause increased brown coloring of the iris, which may be permanent. LUMIGAN® 0.01% can cause darkening of the eyelid skin and eyelashes, which may be reversible after treatment is stopped. The long-term effects of increased dark coloring are not known.

LUMIGAN® 0.01% may slowly increase the growth and thickness of eyelashes, which are usually reversible after treatment is stopped.

Prostaglandin analogs, including bimatoprost, have been reported to cause inflammation inside the eye. Also, treatment with LUMIGAN® 0.01% may make existing inflammation worse.

Macular edema (swelling of the macula), including cystoid macular edema, has been reported during treatment with bimatoprost ophthalmic solution. LUMIGAN® 0.01% should be used with caution in patients without a natural lens, in patients with a torn posterior lens capsule who have an artificial lens implant, or in patients with known risk factors for macular edema.

Avoid allowing the tip of the dispensing bottle to touch the eye, anything around the eye, fingers, or any other surface to avoid contamination by common bacteria known to cause eye infections. Using contaminated solutions can cause serious damage to the eye and loss of vision.

If you have eye surgery, eye trauma or infection, or develop any eye reactions, immediately consult with your physician about continuing the use of LUMIGAN® 0.01%.

LUMIGAN® 0.01% contains an ingredient that may be absorbed by and cause discoloration of soft contact lenses. If you wear contact lenses, remove them before using LUMIGAN® 0.01%. Then wait 15 minutes after using LUMIGAN® 0.01% before you put your contacts back into your eyes.

The most common side effect is eye redness. Other side effects include growth of eyelashes and itchy eyes.

Click here for full LUMIGAN® 0.01% Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1 (800)-FDA-1088.